Prostatic Neoplasms: all 6,484 studies
Page 51 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate CancerStatus unknownNCT01835977Phase 2
- A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerNo longer availableNCT01834209
- Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-TCompletedNCT01833208Not applicable
- Sipuleucel-T and Ipilimumab for Advanced Prostate CancerCompletedNCT01832870Phase 1
- Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical ProstatectomyTerminatedNCT01832831
- Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate BrachytherapyStatus unknownNCT01830166Not applicable
- Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate BiopsiesCompletedNCT01827813Not applicable
- Study of Dasatinib, Androgen Deprivation Therapy and RadiationWithdrawnNCT01826838Phase 1
- Comparison of Two Insertion Technique of I-gelStatus unknownNCT01826565Not applicable
- Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate CancerCompletedNCT01825642Phase 2/3
- Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer PatientsCompletedNCT01823549
- Atorvastatin Before Prostatectomy and Prostate CancerCompletedNCT01821404Phase 2
- A Study of Intra-operative Autologous Retropubic Urethral Sling on Urinary Control After Robot Assisted Radical ProstatectomyCompletedNCT01821209Not applicable
- Analysis of a New Biomarker for Prostate Cancer DiagnosisStatus unknownNCT01819740
- Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate CancerCompletedNCT01819285Phase 3
- Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate CancerTerminatedNCT01817738Phase 1/2
- A Registry for Patients Treated on the Clinical Trial TAX 3503CompletedNCT01813370
- Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate CancerCompletedNCT01813097
- Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical ProstatectomyCompletedNCT01812902Not applicable
- A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01812746Phase 2
- Proton Therapy for High Risk Prostate CancerWithdrawnNCT01811810Not applicable
- Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone MetastasisCompletedNCT01810770Phase 3
- Application of Megavoltage Imaging to Reduce Artifact After Seed ImplantsCompletedNCT01810627
- Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate CancerCompletedNCT01804231Not applicable
- Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate CancerActive, not recruitingNCT01802346Not applicable
- Focal Therapy for Prostate CancerWithdrawnNCT01802307Phase 2
- Tumor TARGET Prostate CancerCompletedNCT01802242Not applicable
- Stem Cells Treatment for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery (HULPURO)CompletedNCT01799694Phase 2
- Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control StudyCompletedNCT01797692Not applicable
- Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate CancerCompletedNCT01796028Phase 2
- A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelCompletedNCT01795703Phase 2
- Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate CancerActive, not recruitingNCT01794403Not applicable
- Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer PatientsCompletedNCT01793077
- Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone AcetateCompletedNCT01792687Phase 1
- Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in HumansCompletedNCT01790451Phase 1
- To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During RadiotherapyStatus unknownNCT01787630Phase 2/3
- Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerActive, not recruitingNCT01786265Phase 2
- Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening ProgramCompletedNCT01786031Not applicable
- A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate CancerCompletedNCT01784913Phase 1/2
- Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate CancerCompletedNCT01784757Phase 1
- Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerCompletedNCT01780701
- Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or BrachytherapyCompletedNCT01777802
- Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET ScanNo longer availableNCT01777061
- Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate CancerStatus unknownNCT01769950Not applicable
- WEUSKOP5723: Prostate Cancer StudyCompletedNCT01767363
- Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRSWithdrawnNCT01766869
- Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With RadiosurgeryStatus unknownNCT01766492
- Hypofractionated Radiation Therapy in Prostate CancerActive, not recruitingNCT01764646Not applicable
- Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate CancerCompletedNCT01764347Not applicable
- Carbohydrate Restriction and Prostate Cancer GrowthCompletedNCT01763944Not applicable
- Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled TrialTerminatedNCT01762956Not applicable
- Xbox Kinect Training in Men With Prostate CancerCompletedNCT01762241Not applicable
- Multiparametric MRI for Prostate Cancer Localization and Characterization: New MethodsTerminatedNCT01761812Not applicable
- Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate CancerCompletedNCT01759836Phase 2
- A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate CancerCompletedNCT01756638Phase 2
- A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy SchemeCompletedNCT01752140Not applicable
- Choline PET/CT and MRI for Targeted Prostate BiopsyCompletedNCT01751737Not applicable
- Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)CompletedNCT01751438Phase 2
- Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate CancerWithdrawnNCT01750866Phase 2
- Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT01748500Phase 2
- Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate CancerWithdrawnNCT01745718Not applicable
- One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese PopulationCompletedNCT01744366Phase 3
- A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical ProstatectomyCompletedNCT01744262Not applicable
- MR-Guided Laser Ablation of Prostate Bed RecurrencesWithdrawnNCT01743638Not applicable
- Prevalence of Neglected Side Effects to Radical ProstatectomyCompletedNCT01742962
- Continuous Monitoring of Prostate Position During RadiotherapyActive, not recruitingNCT01742403Not applicable
- BKM120+Abiraterone Acetate for Metastatic CRPCTerminatedNCT01741753Phase 1
- Dovitinib(TKI258) in Patients With Castration-resistant Prostate CancerCompletedNCT01741116Phase 2
- The ProCaRis Study: Prostate Cancer Risk Assessment in General PracticeActive, not recruitingNCT01739062Not applicable
- UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics StudiesActive, not recruitingNCT01737242
- Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate CancerTerminatedNCT01737151Not applicable
- Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate CancerWithdrawnNCT01734681Phase 2
- Prostate Cancer Active Surveillance Metformin TrialWithdrawnNCT01733836Phase 2
- Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy InitiationCompletedNCT01729676
- Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound ElastographyCompletedNCT01729442Not applicable
- Focal Therapy for Localised Prostate Cancer Using Irreversible ElectroporationStatus unknownNCT01726894Not applicable
- Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHTTerminatedNCT01724619Early Phase 1
- First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate CancerCompletedNCT01723475Phase 1
- Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" RiskTerminatedNCT01717677Not applicable
- A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate CancerCompletedNCT01716702Not applicable
- Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation TherapyCompletedNCT01711892Not applicable
- Treatment of Prostate Cancer With Firmagon®CompletedNCT01710098
- A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate CancerTerminatedNCT01709734Phase 2
- Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel TherapyCompletedNCT01707966Phase 3
- Merging of Endoscopic and Ultrasound Images for Laparoscopic SurgeryTerminatedNCT01705405Not applicable
- GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary TherapyCompletedNCT01704274Phase 2
- Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate CancerTerminatedNCT01704027Phase 2
- Group-based or Individual Information About Disease and Treatment PlanTerminatedNCT01699672Not applicable
- Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate CancerCompletedNCT01697384Phase 3
- Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer PatientsCompletedNCT01696539Not applicable
- Does Protein Restriction Inhibit Prostrate Cancer GrowthCompletedNCT01692587Not applicable
- Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate CancerWithdrawnNCT01692483
- Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the SampleCompletedNCT01692405Not applicable
- Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.CompletedNCT01692262Phase 1
- Mild Cognitive Impairment in Men Following Androgen DeprivationWithdrawnNCT01691976Not applicable
- Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT01688492Phase 1/2
- Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active SurveillanceStatus unknownNCT01687049Phase 2
- A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate CancerWithdrawnNCT01685489Phase 1
- A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateCompletedNCT01685268Phase 1/2
- A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate CancerStatus unknownNCT01685190Phase 2